mHealth and Home Monitoring - 5th Edition: The Number of Devices with Integrated Cellular Connectivity Is Projected To Grow At A CAGR Of 46.3 Percent to 7.1 Million In 2017

DUBLIN, August 15, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/ghk8fj/mhealth_and_home) has announced the addition a new report "mHealth and Home Monitoring - 5th Edition" to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

According to this new research report, around 2.8 million patients worldwide were using a home monitoring service based on equipment with integrated connectivity at the end of 2012. The figure comprises all patients that were using dedicated devices for remote monitoring. Patients using their personal mobile phone, tablet or PC for remote monitoring are not included in this figure.

The data forecasts that the number of home monitoring systems with integrated communication capabilities will grow at a compound annual growth rate (CAGR) of 26.9 percent between 2011 and 2017 to reach 9.4 million connections worldwide. The number of devices with integrated cellular connectivity increased from 0.73 million in 2011 to about 1.03 million in 2012.

mHealth enables more efficient care delivery, decreased costs and improved sustainability of the healthcare system. The new care models enabled by these technologies are often consistent with patients' preferences of living more healthy, active and independent lives.

Widespread use of remote patient monitoring is still years away, but we are moving towards an age where mHealth solutions will become part of standard care pathways. Financial incentives are now coming into place and new mandates are formed that favourably affect the adoption of mHealth solutions.

Several new developments in the mHealth industry will ensure strong market growth in 2013 and beyond. In the US, the progressive increases of readmission penalties set by the Centers for Medicare & Medicaid Services (CMS) will drive hospitals to adopt telehealth solutions for monitoring post-discharge patients.

In the UK, the positive results from the Whole System Demonstrator project led the National Health Service to issue a mandate for 100,000 additional patients to be monitored with telehealth solutions by March 2014. In France, a new mandate on compliance monitoring will ensure that all new sleep therapy patients will be remotely monitored from 2013 onwards. This new mandate is expected to result in more than 600,000 connected sleep therapy devices by 2016.

Some of the Companies Mentioned:

- Abbott Laboratories
- AT&T
- Bayer Healthcare
- Boston Scientific
- Covidien
- Deutsche Telecom
- Epic Systems
- Fisher & Paykel Healthcare
- Grandcare Systems
- Helena Laboratories
- Innospense
- International Technidyne Corporation
- Johnson & Johnson
- KORE Telematics
- LifeWatch
- Medtronic
- NovaSom
- Orange Group
- Philips Respironics
- Proteus Digital Health
- Qualcomm
- Roche
- SK Telecom
- Sprint
- St. Jude Medical
- Telefónica
- Verizon Communications
- Vodafone
- Wireless-Life Sciences Alliance
- Zenicor

For more information visit http://www.researchandmarkets.com/research/ghk8fj/mhealth_and_home

Source: Berg Insight AB

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Telecommunications and Networks

SOURCE Research and Markets